Radiosensitizing biological modifiers enhancing efficacy in non-small-cell lung cancer treated with radiotherapy

Author： Holgersson Georg Bergström Stefan Ekman Simon Brattström Daniel Henriksson Roger Edlund Per Bergqvist Michael

ISSN： 1758-1966

Source： Lung Cancer Management, Vol.2, Iss.4, 2013-08, pp. : 251-255

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Efficacy of the smaller target volume for stage III non-small cell lung cancer treated with intensity-modulated radiotherapy

Molecular and Clinical Oncology, Vol. 3, Iss. 5, 2015-01 ,pp. : 1172-1176

Science Publishers

Access to resources Recommend Favorite

Interstitial lung disease in patients with non-small-cell lung cancer treated with epidermal growth factor receptor inhibitors

By Tsuboi Masahiro Chevalier Thierry

Medical Oncology, Vol. 23, Iss. 2, 2006-06 ,pp. : 161-170

Humana Press, Inc

Access to resources Recommend Favorite

Afatinib in advanced non-small-cell lung cancer

By Di Maio Massimo Gridelli Cesare Grossi Francesco Novello Silvia de Marinis Filippo

Lung Cancer Management, Vol. 2, Iss. 6, 2013-12 ,pp. : 493-504

Future Medicine

Access to resources Recommend Favorite

Rare mutations in non-small-cell lung cancer

By D’Arcangelo Manolo D’Incecco Armida Cappuzzo Federico

Future Oncology, Vol. 9, Iss. 5, 2013-05 ,pp. : 699-711

Future Medicine

Access to resources Recommend Favorite

Evolution of modern-era radiotherapy strategies for unresectable advanced non-small-cell lung cancer

By Selek Ugur Chang Joe Y

Lung Cancer Management, Vol. 2, Iss. 3, 2013-06 ,pp. : 213-225

Future Medicine

Access to resources Recommend Favorite